Acute dosing of latrepirdine (Dimebon), a possible Alzheimer therapeutic, elevates extracellular amyloid- levels in vitro and in vivo

John W. Steele, Soong H. Kim, John R. Cirrito, Deborah K. Verges, Jessica L. Restivo, David Westaway, Paul Fraser, Peter St George Hyslop, Mary Sano, Ilya Bezprozvanny, Michelle E. Ehrlich, David M. Holtzman, Sam Gandy

Research output: Contribution to journalArticle

37 Scopus citations

Fingerprint Dive into the research topics of 'Acute dosing of latrepirdine (Dimebon), a possible Alzheimer therapeutic, elevates extracellular amyloid- levels in vitro and in vivo'. Together they form a unique fingerprint.

Medicine & Life Sciences